LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 4627 | 5383 | 0.8592 | 0.8286 |
BT-20 | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 4510 | 5383 | 0.8379 | 0.8023 |
BT-20 | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 4050 | 5383 | 0.7525 | 0.6918 |
BT-20 | JW-7-24-1 | 10 | uM | LJP6 | 72 | hr | 1657 | 1813 | 5383 | 0.3368 | 0.0536 |
BT-20 | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5156 | 5588 | 0.9227 | 0.9103 |
BT-20 | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 1657 | 2745 | 5383 | 0.5113 | 0.3461 |
BT-20 | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 3500 | 5588 | 0.6268 | 0.5308 |
BT-20 | Dasatinib | 0.12 | uM | LJP6 | 72 | hr | 1657 | 1833 | 5383 | 0.3410 | 0.0613 |
BT-20 | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 1894 | 5588 | 0.3390 | 0.0787 |
BT-20 | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 1657 | 1678 | 5383 | 0.3121 | 0.0071 |
BT-20 | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 1580 | 5588 | 0.2828 | -0.0271 |
BT-20 | Dasatinib | 1.11 | uM | LJP6 | 72 | hr | 1657 | 1453 | 5383 | 0.2706 | -0.0749 |
BT-20 | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 1332 | 5588 | 0.2384 | -0.1176 |
BT-20 | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1159 | 5383 | 0.2156 | -0.1899 |
BT-20 | Dasatinib | 10 | uM | LJP5 | 72 | hr | 1657 | 1283 | 5588 | 0.2298 | -0.1359 |
BT-20 | Dasatinib | 10 | uM | LJP6 | 72 | hr | 1657 | 1008 | 5383 | 0.1878 | -0.2541 |
BT-20 | Tozasertib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 3346 | 5588 | 0.5989 | 0.4915 |
BT-20 | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 1979 | 5588 | 0.3543 | 0.1056 |
BT-20 | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 1657 | 1709 | 5588 | 0.3059 | 0.0175 |
BT-20 | Tozasertib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 1732 | 5588 | 0.3099 | 0.0252 |
BT-20 | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 1627 | 5588 | 0.2912 | -0.0108 |
BT-20 | Tozasertib | 10 | uM | LJP5 | 72 | hr | 1657 | 1660 | 5588 | 0.2971 | 0.0008 |
BT-20 | Imatinib | 0.04 | uM | LJP6 | 72 | hr | 1657 | 5484 | 5383 | 1.0200 | 1.0236 |
BT-20 | Imatinib | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5758 | 5383 | 1.0700 | 1.0813 |
BT-20 | Imatinib | 0.37 | uM | LJP6 | 72 | hr | 1657 | 5458 | 5383 | 1.0140 | 1.0164 |